Trending Stocks
AI-Detected Trends Before They Happen. Daily short-term research ideas with clear reasoning and a live model portfolio of trending stocks.
What “trending stocks” means here
On this page, trending stocks are the names the model is publishing now as short-term research ideas. They are not simply the market’s most-discussed tickers or the biggest one-day movers. Each idea has to pass the site’s selection process, is published with a clear entry date, and stays active for a seven-day holding window before moving into history.
The page separates current ideas, historical ideas, and portfolio-level performance so you can review what is active now, what has already closed, and how the published model record has developed over time.
Get daily or weekly stock research ideas.
Research content for general circulation. Not individualized advice.
Ideas Cumulative PerformanceCompounded
Fresh Ideas
Tue, Sep 8, 2026The newest batch from the model — 7 ideas published on Tue, Sep 8, 2026. Everything opened earlier in the week is in Active Ideas.
META closed at a supplied-period high on September 8 after gaining 8% since August 31. Core advertising remains strong, with cited revenue growth near 26%, rising engagement, and improving AI-powered ad performance.
Exceptional momentum and AI-storage demand: shares rose about 44% over 21 trading days through September 8, Q3 revenue increased 97% sequentially, data-center revenue grew 233%, and Q4 revenue was guided to $7.75-$8.25 billion.
The September 8 positive Phase 2 PHocus update for mosliciguat drove an approximately 20% premarket move and a period-high close. FDA approval of LISRAYA and additional 2026 clinical readouts provide further catalyst support.
Shares gained 18.3% over 21 trading days, supported by stronger gold prices, an expected fourth-quarter production ramp, approximately $1.8 billion of cash, no debt, a reinstated dividend, and a new $500 million buyback authorization.
Shares advanced 30% over 21 trading days and reached a new supplied-data high on September 8. Q2 revenue grew 113%, free cash flow reached $33.6 million, a $100 million buyback was authorized, and a September 9 presentation may add visibility.
Shares rose 14.7% over 21 trading days and closed at the period high on September 8. Recovering margins, positive free cash flow, a UBS Buy upgrade to a $42 target, and the September 10 Investor Day create a timely catalyst.
ADM gained 5.1% over 21 trading days after management raised 2026 adjusted EPS guidance to $5.15-$5.60. Improving ethanol and biofuel margins, Nutrition recovery, and a $500-$750 million cost-reduction program support near-term sentiment.
Closed Ideas
Tue, Sep 8, 2026Every idea that reached the end of its tracking window on the last completed trading day, with the result it actually finished on.
FTH gained 34.8% through September 1 and closed near its period high. The FDA's Fast Track designation for PIKTOR plus paclitaxel provides a recent oncology catalyst, with additional PK/PD and clinical milestones capable of sustaining attention.
TRMD gained 13% through September 1 as record Q2 TCE earnings reached $512 million and full-year guidance increased by $200 million. Strong product-tanker rates, 51% net margin and substantial cash generation reinforce the momentum.
FIVE rose about 11% over 21 sessions after first-quarter sales increased 32.5%, comparable sales grew 22.7%, and management raised its fiscal 2026 outlook. Fiscal Q2 results after the September 2 close provide an immediate five-day catalyst.
RVTY gained 13.3% after Q2 adjusted EPS of $1.41 beat the $1.23 consensus on $730 million of revenue, prompting higher full-year revenue and profit guidance. Diagnostics, AI-enabled drug discovery and the SuperFlex launch add product momentum.
LNG advanced 13.3% over 21 sessions while Cheniere raised its 2026 outlook for a second consecutive quarter. More than 90% of capacity is contracted, and Corpus Christi Stage 3 progress supports production and cash-flow visibility.
Results are the model's tracked entry-to-exit move, before fees and slippage. See the full history.
Currently active model ideas with performance tracking
META closed at a supplied-period high on September 8 after gaining 8% since August 31. Core advertising remains strong, with cited revenue growth near 26%, rising engagement, and improving AI-powered ad performance.
Exceptional momentum and AI-storage demand: shares rose about 44% over 21 trading days through September 8, Q3 revenue increased 97% sequentially, data-center revenue grew 233%, and Q4 revenue was guided to $7.75-$8.25 billion.
The September 8 positive Phase 2 PHocus update for mosliciguat drove an approximately 20% premarket move and a period-high close. FDA approval of LISRAYA and additional 2026 clinical readouts provide further catalyst support.
Shares gained 18.3% over 21 trading days, supported by stronger gold prices, an expected fourth-quarter production ramp, approximately $1.8 billion of cash, no debt, a reinstated dividend, and a new $500 million buyback authorization.
Browse by Sector
Explore stock research ideas organized by industry sectors. Discover companies and investment opportunities across different market segments.
Best Recent Ideas
Top recent model ideas from our AI-powered pipeline with tracked outcomes
Jyong Biotech (MENS) has surged from $7.50 to over $23 post-IPO, showing exceptional short-term strength and clear higher highs/lows. Momentum traders targeting quick gains could capitalize on further follow-through, though underlying liquidity and trial risks remain significant.
USARW exhibits a strong short-term breakout with a 218% surge over 21 trading days well above its 21-day moving average and the upper Bollinger Band, signaling significant momentum. Despite elevated overbought risk, the strong technical strength and sector demand cyclicality make USARW a compelling hot idea for near-term trading gains with cautious risk management.
High-risk semiconductor test beneficiary with an imminent catalyst: multiple recent production orders (FOX wafer-level systems, silicon-photonics and GaN programs), reinstated H2 revenue guidance ($25–30M) and a sharp rebound (~+31% from March 30 to April 1) into the 2026-04-07 Q3 earnings release create a classic near-term event/momentum setup.
AeroVironment has outperformed its sector recently and sits on a technical base around $180–195 ahead of a June earnings release that could validate its strong profitability and revenue growth outlook. The BlueHalo merger adds a fresh growth narrative in drone defense, and the risk/reward looks favorable given the stock’s low leverage and positive analyst sentiment.
Model Ideas History
Complete track record of all published ideas with transparent outcomes.
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 15, 2026 | META | Meta Platforms, Inc. | META closed at a supplied-period high on September 8 after gaining 8% since August 31. Core advertising remains strong, with cited revenue growth near 26%, rising engagement, and improving AI-powered ad performance. | Active | +6.1% |
| Sep 8, 2026 | Sep 15, 2026 | SNDK | Sandisk Corporation | Exceptional momentum and AI-storage demand: shares rose about 44% over 21 trading days through September 8, Q3 revenue increased 97% sequentially, data-center revenue grew 233%, and Q4 revenue was guided to $7.75-$8.25 billion. | Active | +2.1% |
| Sep 8, 2026 | Sep 15, 2026 | ROIV | Roivant Sciences Ltd. | The September 8 positive Phase 2 PHocus update for mosliciguat drove an approximately 20% premarket move and a period-high close. FDA approval of LISRAYA and additional 2026 clinical readouts provide further catalyst support. | Active | +0.8% |
| Sep 8, 2026 | Sep 15, 2026 | SSRM | SSR Mining Inc. | Shares gained 18.3% over 21 trading days, supported by stronger gold prices, an expected fourth-quarter production ramp, approximately $1.8 billion of cash, no debt, a reinstated dividend, and a new $500 million buyback authorization. | Active | +2.2% |
| Sep 8, 2026 | Sep 15, 2026 | LIFE | Ethos Technologies Inc. | Shares advanced 30% over 21 trading days and reached a new supplied-data high on September 8. Q2 revenue grew 113%, free cash flow reached $33.6 million, a $100 million buyback was authorized, and a September 9 presentation may add visibility. | Active | -6.5% |
| Sep 8, 2026 | Sep 15, 2026 | SEDG | SolarEdge Technologies, Inc. | Shares rose 14.7% over 21 trading days and closed at the period high on September 8. Recovering margins, positive free cash flow, a UBS Buy upgrade to a $42 target, and the September 10 Investor Day create a timely catalyst. | Active | -3.4% |
| Sep 8, 2026 | Sep 15, 2026 | ADM | Archer-Daniels-Midland Company | ADM gained 5.1% over 21 trading days after management raised 2026 adjusted EPS guidance to $5.15-$5.60. Improving ethanol and biofuel margins, Nutrition recovery, and a $500-$750 million cost-reduction program support near-term sentiment. | Active | +1.8% |
| Sep 4, 2026 | Sep 11, 2026 | ORCL | Oracle Corporation | Cloud infrastructure revenue rose 93%, remaining performance obligations reached $638 billion, and the stock broke above its prior-period high after gaining 7.4% over 21 sessions. Fiscal Q1 earnings after the September 10 close provide a concrete catalyst within the five-day horizon. | Active | +2.1% |
| Sep 4, 2026 | Sep 11, 2026 | ANF | Abercrombie & Fitch Co. | Q2 revenue and earnings beat expectations, management raised full-year sales, margin and EPS guidance, and announced at least $500 million of FY2026 buybacks. Shares gained 31.7% over 21 sessions and were consolidating near the September 4 breakout level of $148.42. | Active | +0.9% |
| Sep 4, 2026 | Sep 11, 2026 | DAVE | Dave Inc. | Q2 revenue increased 30%, adjusted EBITDA rose 48%, EPS beat consensus, and management raised full-year 2026 guidance. The stock gained 23.5% over 21 sessions and remained 12.7% above its 21-day average on September 4. | Active | -4.5% |
How It Works
Our proprietary pipeline combines AI-powered analysis with systematic validation. Learn more about our methodology and check out our FAQ for details.
AI Analysis
Our pipeline continuously monitors news, earnings reports, technical indicators, and price action across thousands of stocks.
Multi-Layer Filtering
Ideas pass through multi-agent analysis framework: fundamental and news screening, technical confirmation, and risk assessment.
Publication & Alerts
Validated model ideas are published with clear reasoning. You may opt in to receive publication alerts.
How ideas are published and tracked
New ideas are published every business day. The system applies structured filters and a systematic research process, then posts the names that qualify for the current cycle. The homepage is built to separate what is live now from what has already finished:
- Active Ideas are the current seven-day ideas, with live performance while that window is open.
- Model Ideas History is the archive of closed ideas after their seven-day period ends.
- Ideas Cumulative Performance shows the compounded model-portfolio result across published ideas, using the site’s performance rules.
That distinction matters. A stock can be active today, then move into history once its window closes, while the cumulative chart keeps tracking the portfolio-level record across time rather than the result of any single name.
You can review current ideas in Active Ideas, browse past published ideas in Model Ideas History, and use Methodology & Disclosures for the calculation framework.
Frequently Asked Questions
Everything you need to know about Trending Stocks.
Important Legal Disclaimer
Not Investment Advice: All content on this platform is provided for informational and educational purposes only. Nothing on this site constitutes investment advice, financial advice, trading advice, or any other sort of advice.
No Guarantees: Past performance is not indicative of future results. All investments carry risk, and you may lose some or all of your capital.
Do Your Own Research: You are solely responsible for your own investment decisions. Always conduct thorough research and consider consulting with a qualified financial advisor.
Data Accuracy: While we strive for accuracy, we make no warranties about the completeness, reliability, or accuracy of information provided.
By using this service, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.